APA (7th ed.) Citation

Carvalho, R. F., Canto, L. M. d., Cury, S. S., Hansen, T. F., Jensen, L. H., & Rogatto, S. R. (2021). Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Carvalho, Robson Francisco, Luisa Matos do Canto, Sarah Santiloni Cury, Torben Frøstrup Hansen, Lars Henrik Jensen, and Silvia Regina Rogatto. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG, 2021.

MLA (8th ed.) Citation

Carvalho, Robson Francisco, et al. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG, 2021.